SCHEMBL16296272

SCHEMBL16296272

CC(C)(C)N(C(=O)O)[C@H]1C[C@H](CI)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16296275 1.00
SCHEMBL16936695 0.85
SCHEMBL16936694 0.85
SCHEMBL1847734 0.85 NR1H2 (0.37)
SCHEMBL1847732 0.85 NR1H2 (0.37)
SCHEMBL1847742 0.83 GABRR1 (0.35)
SCHEMBL1847743 0.83 GABRR1 (0.35)
SCHEMBL11901542 0.78 CHRM2 (0.32)
SCHEMBL1583178 0.78 CHRM2 (0.32)
SCHEMBL1583177 0.78 CHRM2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9834527-B2 Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals SANOFI (FR) 2017-12-05 US disclosed
EP-3027611-B1 MACROCYCLIC UREA DERIVATIVES AS INHIBITORS OF TAFI A, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2017-07-26 EP disclosed
EP-3027611-A1 MACROCYCLIC UREA DERIVATIVES AS INHIBITORS OF TAFI A, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2016-06-08 EP disclosed
US-20160137618-A1 Macrocyclic Urea Derivatives as Inhibitors of TAFIa, Their Preparation and Their Use as Pharmaceuticals SANOFI (FR) 2016-05-19 US disclosed
WO-2014198620-A1 MACROCYCLIC UREA DERIVATIVES AS INHIBITORS OF TAFIA, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2014-12-18 WO disclosed